Skip to main content

Table 2 Baseline characteristics of ESCC patients and the correlation with RABL6 expression

From: High expression of RABL6 promotes cell proliferation and predicts poor prognosis in esophageal squamous cell carcinoma

Characteristics Total [cases (%)] RABL6 expression [cases (%)] P value
N = 171 High
N = 96
Low
N = 75
 
Age (years)     0.040
 ≤ 55 79 (46.2) 45 (26.3) 34 (19.9)  
 > 55 92 (53.8) 51 (29.8) 41 (24.0)  
Gender     0.320
 Male 129 (75.4) 74 (43.2) 55 (32.2)  
 Female 42 (24.6) 22 (12.9) 20 (11.7)
Tumor location     0.132
 Upper 13 (7.6) 8 (4.7) 5 (2.9)  
 Middle 114 (66.7) 69 (40.4) 45 (26.3)  
 Low 44 (25.7) 19 (11.1) 25 (14.6)  
Lymph-vascular invasion     0.000
 Yes 79 (46.2) 56 (32.7) 23 (13.5)  
 No 92 (53.8) 40 (23.4) 52 (30.4)  
Perineural invasion     0.139
 Yes 63 (36.8) 40 (23.4) 23 (13.5)  
 No 108 (63.2) 56 (32.7) 52 (30.4)  
Histological differentiation     0.282
 Well 39 (22.8) 22 (12.9) 17 (9.9)  
 Moderate 93 (54.4) 48 (28.1) 45 (26.3)  
 Poor 39 (22.8) 26 (15.2) 13 (7.6)  
Pathological stage     0.374
 I & II 103 (60.2) 55 (32.2) 48 (28.1)  
 III & IV 68 (39.8) 41 (23.9) 27 (15.8)  
Lymph node metastasis     0.162
 No 90 (52.6) 46 (26.9) 44 (25.7)  
 Yes 81 (47.4) 50 (56.1) 31 (18.1)